Baudax Bio, Inc. announced that it has entered into a share purchase agreement for the gross proceeds of $50 million on August 23, 2023. The transaction will include participation from new investor, Alumni Capital LP.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.00766 USD | +7.89% | -26.67% | -65.00% |
Feb. 22 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
2023 | Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-65.00% | 372K | |
+29.13% | 49.18B | |
+0.96% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.29% | 26.09B | |
-22.70% | 18.71B | |
+8.15% | 13.26B | |
+32.02% | 12.32B | |
-0.71% | 11.99B |
- Stock Market
- Equities
- BXRXQ Stock
- News Baudax Bio, Inc.
- Baudax Bio, Inc. announced that it expects to receive $50 million in funding from Alumni Capital LP